logo
  

Intuit Reaffirms Q1, FY22 Outlook - Quick Facts

Ahead of its virtual Investor Day later on Thursday, technology platform Intuit Inc. (INTU) reaffirmed its financial guidance for the first quarter and full fiscal year 2022.

For the first quarter, the company continues to expect earnings in a range of $0.14 to $0.19 per share and adjusted earnings in a range of $0.94 to $0.99 per share on revenue growth of approximately 36 to 38 percent, including Credit Karma.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $0.99 per share on revenues of $1.81 billion for the quarter. Analysts' estimates typically exclude special items.

Looking ahead to fiscal 2022, the company still projects earnings in a range of $7.46 to $7.66 per share and adjusted earnings in a range of $11.05 to $11.25 per share on revenue between $11.050 billion and $11.200 billion, a growth of approximately 15 to 16 percent, including a full year of Credit Karma.

The Street is looking for earnings of $11.24 per share on revenues of $11.16 billion for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The five-day holiday shopping period from Thanksgiving Day through Cyber Monday saw about 180 million Americans making in-store and online purchases, according to the National Retail Federation's Annual Thanksgiving Weekend Consumer Survey, conducted by Prosper Insights & Analytics. The shoppers spent an average of $301.27 on holiday-related purchases such as gifts, décor, apparel and toys. Biopharmaceutical company Immunome, Inc. (IMNM) announced Wednesday that it has conducted an assessment of the reported mutations in the new SARS-CoV-2 variant, Omicron (B.1.1.529). Based upon structural mapping of those mutations and activity against previous and current CDC variants of concern,... CVS Health said it has installed time delay safe technology in all 392 Illinois CVS Pharmacy locations, including those in Target stores, to help reduce organized retail crime. The installation of new safes for controlled substances are anticipated to help prevent pharmacy robberies. There is also potential for associated diversion of controlled substance medications, including opioid medications.
Follow RTT